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Background: Although feline immunodeficiency virus (FIV) and feline leukemia virus (FeLV) have similar risk factors
and control measures, infection rates have been speculated to vary in geographic distribution over North America.
Since both infections are endemic in North America, it was assumed as a working hypothesis that their geographic
distributions were similar. Hence, the purpose of this exploratory analysis was to investigate the comparative
geographical distribution of both viral infections. Counts of FIV (n=17,108) and FeLV (n=30,017) positive serology
results (FIV antibody and FeLV ELISA) were obtained for 48 contiguous states and District of Columbia of the United
States of America (US) from the IDEXX Laboratories website. The proportional morbidity ratio of FIV to FeLV
infection was estimated for each administrative region and its geographic distribution pattern was visualized by a
choropleth map. Statistical evidence of an excess in the proportional morbidity ratio from unity was assessed using
the spatial scan test under the normal probability model.
Results: This study revealed distinct spatial distribution patterns in the proportional morbidity ratio suggesting the
presence of one or more relevant and geographically varying risk factors. The disease map indicates that there is a
higher prevalence of FIV infections in the southern and eastern US compared to FeLV. In contrast, FeLV infections
were observed to be more frequent in the western US compared to FIV. The respective excess in proportional
morbidity ratio was significant with respect to the spatial scan test (p < 0.05).
Conclusions: The observed variability in the geographical distribution of the proportional morbidity ratio of FIV to
FeLV may be related to the presence of an additional or unique, but yet unknown, spatial risk factor. Putative
factors may be geographic variations in specific virus strains and rate of vaccination. Knowledge of these factors
and the geographical distributions of these infections can inform recommendations for testing, management and
prevention. However, further studies are required to investigate the potential association of these factors with FIV
and FeLV.
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Infections with feline immunodeficiency virus (FIV) and
feline leukemia virus (FeLV) are common and important
conditions in cats [1]. Both FIV and FeLV are immunosup-
pressive retroviruses and associated with a wide array of
disease conditions affecting multiple organ systems and
susceptibility to opportunistic infections. The most im-
portant mode of transmission of both retroviruses is
through bites, although other less common modes of
transmission such as nursing, mutual grooming or sharing
dishes for FeLV [2]; and in utero [3], experimental infec-
tion via vaginal mucosa [4], and nursing in neonates [5]
for FIV have been reported. Cats at high risk of encounter-
ing and fighting with infected cats, and thus getting
infected, include those with outdoor lifestyles, and those
that are male, adult and non-neutered [6-11].
There is great interest in developing diagnostic tests to
identify vaccinated and infected cats and to develop better
vaccines to protect uninfected animals [11]. However, little
progress has been made in understanding the distribution
and causes of FeLV and FIV infections in cat populations.
Such knowledge about the prevalence of both infections
would assist in defining prophylactic, management and
therapeutic measures for stray, feral, and owned cats [12].
Recent studies estimate a sero-prevalence of 2.3% (FeLV)
and 2.5% (FIV) in the US [11], and 3.4% (FeLV) and 4.3%
(FIV) in Canada [13].
A number of studies suggested that the prevalence of
retroviral infections in domestic cat populations may
represent regional patterns of infection, which is likely at-
tributable to variable population density, reproductive sta-
tus, age, gender and housing conditions [14-16]. A study
from Vietnam reported FIV sero-prevalence to be higher
in the south when compared to the north [17]. Similarly,
in Germany, differences in prevalence of FIV between
northern and southern states have been reported and
attributed to lifestyle, sex and health status of cats [18].
However, regional differences in the US and Canada were
still present after adjusting for similar factors [11,13]. Fur-
thermore, even though both infections are known to share
similar risk factors, it is unclear whether they also have
unique risk factors. Interestingly, in some studies cats tend
to have co-infections with both viruses [13,19], whereas in
other studies the reverse was shown [20,21]. These contra-
dictory results, and residual variation in sero-prevalence
after adjusting for risk factors, might be expressions of
geographic variation in the sero-prevalence [11] or un-
known spatial factors, which have not yet been explored.
Further, geographical variation in the distribution of FIV
and FeLV infections has been suggested previously but has
not yet been studied using spatial statistics [11,13,22,23].
In this study, we explored the geographical distribution
of both viral infections relative to each other in 49 admi-
nistrative regions (48 contiguous states and the District ofColumbia) of the US. If underlying known or unknown
risk factors for FIV and FeLV infections vary geographic-
ally, then regions with excesses of one infection over the
other should exist. The objective of this study was to a)
describe the geographical distribution and b) detect high




Counts of FIV (n=17,108) and FeLV (n=30,017) positive
serological tests (FIV antibody and FeLV ELISA) were
obtained for each of the 49 administrative regions of the
US from the IDEXX laboratories’ public access website on
FIV, FeLV and heartworm infections [24]. The data en-
compass positive test results for FIV and FeLV from
IDEXX sponsored prevalence studies [11,25], IDEXX
VetLab Station data reported from veterinary practices,
and IDEXX reference laboratories' results collected from
2000 to 2011 [24]. The screening serology for FIV and
FeLV entails use of antigen and antibody capture Enzyme-
Linked Immunosorbent Assays (ELISA) [26], with sensi-
tivities of 100% and 97.6% and specificities of 99.5% and
99.1%, respectively. The assay tests for both viruses in a
combined kit format. Each administrative region was geo-
referenced to latitude and longitude coordinates of the
respective administrative region centroid. These centroids
were extracted from the digital map of the US states, in
Environmental System Research Institute (ESRI) shapefile
format [27] obtained from the US Census Bureau's 2010
geographic data website [28], using the R statistical soft-
ware [29].
Disease mapping - choropleth maps
The proportional morbidity ratio (PMR) of FIV to FeLV
infection was estimated for each administrative region and
a choropleth disease map was used to visualize the spatial
pattern of PMR. Choropleth maps represent regional
values such as the prevalence by colour scales where each
scale represents a discrete value or a range of values [30].
All maps were displayed in Albers equal area conic
projection.
Conventionally, a proportional morbidity/mortality ratio
for a particular disease is the observed proportion of ill-
ness/death due to a cause over the expected proportion.
The expected proportion is the number of illness/death in
a reference population from the specific cause over all ill-
ness/death in that population [31]. The PMR is likewise
defined as the ratio of two morbidity measures, such as
the sero-prevalence for two infections:
PMR ¼ p1=p2 ¼ m1=n1ð Þ= m2=n2ð Þ;
where m1 and m2 denote the number of cases for FIV and
Table 1 Descriptive statistics of FIV and FeLV infections,
and the proportional morbidity ratios (PMR)
Parameters Mean Median Range
Number of FIV Positives 349 92 4 - 4610
Number of FeLV Positives 612 163 3 - 9113
PMR 0.79 0.72 0.04 - 2.05
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the number of tested cats for the respective infections.
For the present study only the total number of cats that
tested positive for either infection was available. However,
cats are typically tested with a dual ELISA test that is able
to detect antibodies to FIV as well as FeLV antigens [32] at
the same time. Furthermore, the American Association of
Feline Practitioners recommends testing for both infec-
tions at the same time [9,33]. Therefore, on the assump-
tion that a combination ELISA was applied to test for
both infections simultaneously, the number of tested indi-
viduals is the same for both infections (i.e., n1 = n2).
Therefore the PMR formula reduces to PMR = m1/m2.
Therefore, the PMR (FIV, FeLV) equals the number of cats
testing positive for FIV over the number of cats testing
positive for FeLV. An area, or administrative region, with
PMR >1 represents an excess of FIV infections compared
to FeLV infections. Alternatively, a PMR <1 for an area
indicates excess of FeLV infections relative to FIV infec-
tions in that area. Respective PMRs for each administra-
tive region were visualized as choropleth maps using
breaks based on the quintiles of the empirical distribution
of the 49 administrative region PMRs.
Disease cluster detection - spatial scan test
In order to compare the relative distribution of FIV to
FeLV (i.e., the PMR), data were aggregated to adminis-
trative region centroids. Statistically significant high risk
clusters of FIV (or FeLV) infection were identified using
a weighted normal spatial scan test [34] as implemented
in SaTScan™ [35]. Since the PMR is a continuous vari-
able and its geographical distribution was of interest, the
spatial scan test based on the normal probability model
was used to detect clusters of high or low PMRs. The
normal spatial scan statistic applies to continuously dis-
tributed data and not just Gaussian, i.e. normally distrib-
uted data [34]. Moreover, the “weighted” version of the
normal spatial scan test was used, which allows to adjust
for varying regional uncertainty in the PMR estimates,
due to varying sample sizes. The weights for each of the
49 administrative regions were estimated as the mean of
the total number of cats testing positive for FIV and
FeLV infections in each region.
The spatial scan test identifies potential clusters of
high or low risk by moving circular windows of varying
radius (size) and location (region centroids) across the
study area. The one-sided test was performed to identify
significant high and low risk clusters. A high risk cluster
was defined as an aggregation of administrative regions
with mean PMR >1 (i.e. neighbouring regions in which
FIV was more frequent), and a low risk cluster for mean
PMR <1 (i.e. neighbouring regions in which FeLV was
more frequent). The null hypothesis of the one-sided
spatial scan test states the mean of the PMR as constantthroughout the study area, i.e. not different inside and
outside the scanning window [34]. The weighted normal
spatial scan statistic therefore identifies as a cluster a
group of two or more regions with mean PMR higher or
lower than outside the cluster.
The maximum window size was set to 50% of all
administrative areas. A p-value was obtained by Monte
Carlo hypothesis testing with 999 iterations and the
significance level was chosen to be α = 0.05. Areas of
relative FIV excess identified by the spatial scan statistic
were visualized by highlighting the boundaries of the
states included in the most likely cluster on a choropleth
map of the PMR of FIV to FeLV infection. The same
approach was used to visualize areas of FeLV excess.
Results
The descriptive statistics of the data are presented in
Table 1. A total of 14/49 administrative regions had a
proportional morbidity ratio (PMR) >1 and 35/49
administrative regions had a PMR <1. PMR ranged from
0.04 to 2.05. The FIV and FeLV infections had distinct
spatial distribution patterns. The choropleth map
revealed more frequent infection with FIV compared to
FeLV in the southern and eastern US. In contrast, FeLV
infections were observed more frequently in the western
and north-central US compared to FIV (Figure 1).
The spatial scan test detected two high risk clusters.
One high risk cluster consisted of administrative regions
having an excess of FIV infections (Mean PMR =1.03, p
<0.05, 24 administrative regions), and the other high risk
cluster consisted of administrative regions having an ex-
cess of FeLV infections (Mean PMR = 0.14, p < 0.005, 7
administrative regions) (Table 2 and Figure 1).
Discussion
This exploratory analysis identified that areas of relative
excess of FIV and FeLV exist in the US. Both the choro-
pleth maps of PMR and the spatial scan test for evidence
of high risk clusters identified similar areas of relative
excess of one infection over the other. Since it is
assumed that both infections share similar risk factors, it
would be expected that the occurrence of both infec-
tions relative to each other would be more or less uni-
form throughout the US. However, our spatial analyses
show that higher numbers of FIV infections were







Figure 1 Choropleth map of proportional morbidity ratios (PMR) of FIV to FeLV infection in the US. Colors on the map depict the range
of PMR values for 48 contiguous states and District of Columbia of the US. Red and blue borders indicate high risk areas of FIV and FeLV infection
relative to each other. These high risk areas were identified as 'clusters' by spatial scan test using a weighted normal model. Areas with blue
borders depict administrative regions where FIV infections are greater than FeLV among cats. Areas with red borders indicate administrative
regions where FeLV infections in cats are greater than FIV.
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were observed to be higher in the western and north-
central US compared to FIV infections. These results
suggest that the relative excesses of one infection over
the other may be the result of different factors affecting
these geographical areas. The distinct pattern in the geo-
graphical variation of the PMR can be explained in a
number of ways relating to the agent, environment and
host factors. For example, the dominant viral strain
might vary over the study area. Furthermore, vaccination
management, level of veterinary care, and thus the age
and survival times of cats, may differ from place to
place.
Factors that play a role in promoting aggression and
bites are known to be most important in the transmis-
sion of infection from one cat to another for both FIV
and FeLV. These known risk factors include feline popu-
lation type (pet, stray and feral), cat density, sex, age,
neutering status, and access to outdoors [6,7,11]. Previ-
ous studies indicated that FeLV infection is age
dependent and primarily acquired by “friendly” cats
through prolonged close contact between virus shedders
and susceptible cats involving mutual grooming, sharing
of food and water dishes, and use of common litter areasTable 2 Characteristics of high risk areas (clusters) detected b
Cluster Type Inside cluster
Number of states Mean PMR Number
FIV 24 1.03 25
FeLV 7 0.14 42[36]. However, other studies have indicated adulthood,
outdoor lifestyle, neutering status, and fighting to be
associated with FeLV as well [11,13,18]. Thus, it is diffi-
cult to discern whether these known risk factors, being
unique to one infection or the other, could lead to such
geographical variability, and results suggest the existence
of an unknown spatial risk factor. Further, previous stu-
dies have found differences in sero-prevalence across the
US despite controlling for these factors [11].
Identification and segregation have been the most
important tools in the control of both infections [9].
Although a FIV vaccine was introduced in 2002 in the
US, its efficacy remains controversial; whereas vacci-
nation has been attributed as a factor associated with
the decreasing prevalence of FeLV [9]. It is possible that
the prevalence of vaccination may influence the infec-
tion patterns observed in this study. The decision to vac-
cinate a pet would be dependent on owner compliance
and related to their socio-economic status, and these
factors would vary geographically.
Previous studies have found that approximately 50%
and 80% of FeLV infected cats in multi-cat households
are likely to die in the two and three years following
diagnosis, respectively [37,38]. On the other hand,y spatial scan test for FIV and FeLV infections
Outside cluster Cluster radius (kms) p-value
of states Mean PMR
0.35 1688.96 0.02
0.95 1127.96 0.002
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secondary diseases, and FIV is not thought to cause
severe clinical illness in naturally infected cats until
advanced age. In fact, with proper care FIV infected cats
can live for many years [39]. Therefore, one would
expect to find more FIV than FeLV survivors when sam-
pling from, on average, older populations. Further, cats
testing positive for FeLV are likely to be much younger
than those testing for FIV, which also implies that most
older cats that are FIV positive are more likely to be
pets, and therefore may belong to people of higher
socioeconomic status than cats that are young, FeLV
positive, and more likely to be owned by shelters or
catteries.
Different viral clades or strains of FIV are known to
predominate in different geographical regions and could
reflect the patterns observed in this study. Although
clade-specific information was not available for this
study, clade A viruses are common in the western US,
whereas clade B viruses predominate in the eastern US
[40]. However, the association between viral clades and
pathogenicity is unclear [41].
It is important that limitations be considered when
interpreting results from this study. The observed vari-
ability in infection could be reflective of diagnostic sub-
missions specifically to IDEXX laboratories. This could
lead to admission risk bias, a form of selection bias, as is
common with registry or hospital based studies, particu-
larly if preference of diagnostic lab by sample submitters
in an area is related to the true prevalence of either FIV
or FeLV.
Further, sero-prevalence of co-infections with FIV and
FeLV ranging from 0.3% to 1.6% have been reported in
North American cats [11,13,19,42]. However, estimation
of the PMR assumes both the infections to be independ-
ent of each other. Not accounting for coinfections would
lead to biased estimates of the PMR. However, as the
proportion of coinfections increases, the PMR converges
to 1; this means the bias is towards the null. Thus, the
PMR estimate in this study is rather conservative, i.e.
less extreme. Similarly, the result of the spatial scan test
is believed to be conservative, i.e. any significant results
are truly significant.
The scan test used in this study implements circular
shaped windows to detect clusters which may pose a
problem when the outcome of interest is aggregated in a
non-circular fashion. The scan test may, for example,
detect a larger circular high risk cluster by including
surrounding regions of low risk [43]. Though other
non-circular scan tests have been proposed in the litera-
ture, none allow for continuously distributed spatial
observations such as PMRs.
For this study, an exploratory approach was applied to
compare two similar infections and explore the areas ofrelative excess rather than derive risk estimates for each
area primarily because the underlying population (total
number of tested cats in each administrative region) was
not known. Such an approach has been reported in the
veterinary literature to compare relative excess of one
disease to the other [44]. An advantage of these study
designs (e.g. case-case study) is that factors may be iden-
tified as more important for one disease than the other.
The evidence of distinct clusters of infection necessi-
tates the need to investigate overall spatial dependence
in the occurrence of cases (clustering), and if these are
identified, to adjust for their presence when evaluating
the association of putative risk factors to these infec-
tions. Ignoring clustering may result in biased standard
errors and thus can compromise risk factor studies [45].Conclusions
In this study we have identified geographical patterns in
the distribution of the proportional morbidity ratio of
FIV to FeLV infection among cats in the 49 administra-
tive regions of the US over the period 2000 to 2011.
These patterns might be an expression of geographic
variation in the pathogenicity of viral strains that are not
evenly distributed in the study area, reflect geographical
differences in vaccination practices or relate to differ-
ences in survival times after infection. Further studies
are warranted to explore the association of these pro-
posed factors with respective infections that allows for
adjustment of spatial clustering if present in the data.
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